The practice occasionally participates in clinical research trials as part of its ongoing commitment to achieving excellence in the care of its patients. The practice does not engage in research for the purpose of financial gain and only participates in projects which it believes have the potential to achieve significant improvements in the healthcare of its patients. Details of current and recent research projects will be displayed below.
We are currently recruiting patients for the Barack-D trial in collaboration with the Primary Care Clinical Trials Unit at the University of Oxford. Barack-D means “Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease”. Many patients have impaired functioning of their kidneys and this trial explores the use of a well-known diuretic (water tablet) called spironolactone as a treatment to prevent complications associated with reduced kidney function. If you have a level of reduced kidney function called CKD-3B, then you may receive a letter from us asking you to consider participating in this trial, and we do hope that you will give this serious consideration. Half of the patients recruited will be randomly allocated to receive the additional treatment with spironolactone and half will continue with standard care alone. The trial continues for a period of three years. Click here for further information on the Barack-D website.